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Abstract 
The interplay of guest encapsulation and release mechanisms in nanoscale metal-organic 
vehicles and its effect on the drug delivery kinetics of these materials were investigated via a 
novel multidisciplinary approach. Two rationally-designed molecular guests were synthesised, 
which consist of a red-fluorescent benzophenoxazine dye convalently tethered to a coordinating 
catechol group and a protected, non-coordinating catechol moiety. This allowed loading of the 
guests into compositionally and structurally equivalent coordination polymer particles through 
distinct encapsulation mechanisms: coordination and mechanical entrapment. The two types of 
particles delivered their fluorescent cargo with remarkably different kinetic profiles, which could 
be satisfactorily modelled considering degradation- and diffusion-controlled release processes. 
This demonstrates that careful selection of the method of guest incorporation into coordination 
polymer nanoparticles allows selective tuning of the rate of drug delivery from these materials 
and, therefore, of the time window of action of the encapsulated therapeutic agents. 
Introduction 
Coordination polymer particles (CPPs) have recently emerged as a novel family of metal-organic 
materials formed by self-assembly of metal ions and polydentate bridging ligands.1,2 Together 
with crystalline metal-organic frameworks (MOFs), CPPs have been proposed for a large variety 
of applications owing to the intrinsic versatility of coordination chemistry, which allows the 
properties of the final materials to be rationally tailored by proper choice of metals and ligands.3 
Of special interest is the use of CPPs in medicine, which is predicted to have a broad impact in 
the fields of bioimaging and drug delivery.4,5,6 Since the pioneering work from Mirkin and co-
workers in 2005,1 an increasing number of reports have indeed described the successful 
application of nanoscale coordination polymer particles to encapsulate and release therapeutic 
agents.6 Nonetheless, the use of CPPs for drug delivery is in its fledgling stage. A detailed 
rationalisation of guest encapsulation and release mechanisms is still required to understand the 
drug delivery kinetics of most CPPs and, consequently, to fully assess their potential use as 
nanocarriers for therapeutic purposes. While these issues have already been subject of extensive 
debate for biodegradable organic polymer vehicles as drug delivery systems,7,8,9 little attention 
has so far been paid to them in the case of the emerging CPP-based materials.  
Incorporation of the active molecules in coordination polymer nanoparticles usually proceeds 
via two distinct strategies: (1) binding of the drug to the polymer framework as a CPP building 
block10,11,12,13,14 and (2) mechanical entrapment of the therapeutic agent within the metal-organic 
matrix.15,16,17 Accordingly, drug release can take place though different mechanisms, namely 
slow particle degradation via surface erosion, fast diffusion processes and/or a combination of 
both. This scenario can be even more intricate if undesired desorption from the particle surface 
occurs. As a result, complex drug delivery profiles are often encountered in CPPs that preclude 
unambiguous elucidation of the relationship between encapsulation and release mechanisms.5,16 
To share more light into this issue, we have envisioned the fabrication of morphologically 
equivalent CPPs bearing a fluorescent guest that can be either coordinated to the polymer 
backbone (M1) or physically encapsulated within the particle (M2). These two materials 
therefore represent excellent benchmark systems to comparatively investigate degradation- and 
diffusion-controlled drug release processes in CPPs. A schematic representation of this approach 
is shown in Fig. 1. The molecular guest of choice for these studies is a red-fluorescent 
benzophenoxazine dye convalently linked to a coordinating catechol group, both in its non-
protected (1) and protected forms (2). On the other side, cobalt nanoparticles with general 
composition [Co(bix)(3,5-dbsq)(3,5-dbcat)] were used as carriers, where bix is a flexible 
bisimidazole bridging ligand and 3,5-dbsq and 3,5-dbcat stand for the semiquinonate radical and 
catecholate forms of the 3,5-di-tert-butylcatechol.15,16,18 Although analogous CPPs containing 
ZnII ions and bix ligands have already been reported and evaluated for drug delivery 
applications,15,16 the choice of [Co(bix)(3,5-dbsq)(3,5-dbcat)] nanoparticles is justified by: (1) 
the high affinity of catechol groups to coordinate to cobalt ions, which provided us with a simple 
way to incorporate the fluorescent guest to the polymer backbone in M1 without modification of 
the coordination sphere; (2) the well-known optical properties of [Co(3,5-dbsq)(3,5-dbcat)(N-N)] 
units,19 which must result in efficient fluorescence quenching of compounds 1 and 2 while they 
remain in the interior of the nanoparticles and, therefore, allow for selective detection of the 
released guest molecules; and (3) the valence tautomerism exhibited by [Co(bix)(3,5-dbsq)(3,5-
dbcat)] CPPs,18 which can be exploited to assess the morphological similarities between M1 and 
M2. 
Results and Discussion 
Synthesis and characterization of fluorescent guests 1 and 2. Scheme 1 shows the synthetic 
route followed to obtain 1 and 2. Briefly, the tert-butylation and subsequent allylic oxidation of 
commercial 2-methoxy-4-methylphenol gave known aldehyde 3 in 97% yield,20 which is a 
common intermediate for both target compounds. At this point, synthetic pathways diverged, 
either temporally protecting the hydroxyl groups of the catechol moiety as the corresponding 
methoxymethylethers, foresighting to obtain compound 1, or permanently derivatizating them as 
the methyl ethers found in compound 2. Thus, known intermediate 4a was obtained from 3 by 
sequential demethylation with BBr3, and protection of the corresponding catechol with 
methoxymethylbromide (90% overall yield).21 Methylation of the free hydroxyl of compound 3 
gave previously described derivative 4b (90%).22 
Next synthetic steps are analogous for both target compounds. The Wittig reaction between 
aldehydes 4a and 4b and the stabilized phosphorane 2-(triphenylphosphoranylidene) acetonitrile 
afforded the corresponding olefins 5a (96% yield) and 5b (72% yield), as mixtures of Z- and E- 
isomers. Successive hydrogenation of the alkene moieties, at high pressure of H2 under Pd/C 
catalyst, and nitriles, with LiAlH4, furnished amines 7a and 7b in 61 and 51% overall yields for 
both reduction reactions, respectively. After this, troublesome formation of amides 8a (31% 
yield) and 8b (35% yield) was achieved by reaction between amines 7a and 7b and 3-
(naphthalen-1-ylamino) propanoic acid, using 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide 
(EDCI) as coupling agent.23 Compounds 1 and 2 were finally obtained by reaction between 
naphthylamines 8a and 8b and N-ethyl-5-hydroxy-2-methyl-4-nitrosobenzenaminium chloride in 
methanol, under acidic catalyst and reflux temperature (45% and 35% yield for 1 and 2, 
respectively).24 Importantly, this last step did not only allow the benzophenoxazine dye group of 
both fluorescent guests to be constructed, but also concomitant cleavage of the 
methoxymethylethers to eventually obtain compound 1. 
Once synthesised, the optical properties of compounds 1 and 2 were investigated in detail. Fig. 
2 plots the absorption and fluorescence emission spectra of these species in methanol, which are 
mainly governed by the optical transitions corresponding to their benzophenoxazine dye unit. As 
a result, compounds 1 and 2 display equivalent absorption (λmax,1=625 nm, λmax,2=626 nm, 
εmax,1=εmax,2=4.8x104 M-1 cm-1) and emission bands (λmax,1=643 nm, λmax,2=645 nm), which 
resemble those reported for similar derivatives. 25  Importantly, covalent tethering of the 
benzophenoxazine unit to catechol and o-methoxyanisole groups in 1 and 2 does not quench its 
inherent emissive behaviour, the resulting dyads thus presenting high fluorescence quantum 
yields (Φf,1=0.40, Φf,2=0.41). Together with their long-wavelength absorption and emission 
spectra, this makes compounds 1 and 2 ideal fluorescent reporters to monitor guest release from 
CPPs as well as particle degradation. 
Fabrication and characterization of M1 and M2 CPPs. Adapting an experimental procedure 
previously published by us,18 coordination polymer particles M1 and M2 were prepared by 
reaction of CoII ions with the ditopic ligands 1,4-bis(imidazol-1-ylmethyl)benzene and 3,5-di-
tert-butylcatechol in the presence of guest compounds 1 and 2 (Fig. 3a). This led to the formation 
of [Co(bix)(3,5-dbsq)(3,5-dbcat)] polymers, which readily precipitated as nanoparticles due to 
their low solubility in the reaction medium. The resulting CPPs were subsequently collected by 
centrifugation, washed with 5:1 water:ethanol mixtures until no red fluorescence was observed in 
the supernatant solution, and finally dried. For comparison purposes, guest-free coordination 
polymer nanoparticles (M0) were also prepared using this methodology. Noticeably, very small 
amounts of compounds 1 and 2 were used in the preparation of materials M1 and M2 
(catechol:guest molar ratio ~ 100:1). With such low doping loads we intended to minimize the 
effect of the fluorescent guests on the formation of the nanoparticles, which should allow us to 
unambiguously ascribe the differences observed in their release profiles to the occurrence of 
distinct guest incorporation and delivery mechanisms. 
Formation of morphologically equivalent CPPs was indeed revealed by scanning (SEM) and 
transmission (TEM) electron microscopy images (Fig. 3b-c and see also Fig. S1 in the 
Supporting Information). In all cases nanometer-sized solid particles with spherical shapes and 
rather uniform and similar diameters (195 ± 38, 152 ± 22 and 185 ± 37 nm for M0, M1 and M2, 
respectively) were obtained. X-ray diffraction experiments confirmed the amorphous character 
of these materials, while spectroscopic characterisation upon dissolution of the nanoparticles in 
degassed methanol revealed the occurrence of different electronic absorption bands arising from 
their constituent functional units (Fig. 4a). Thus, an absorption band at λ∼625 nm was selectively 
found in the spectra of M1 and M2, which corresponds to the fluorescent benzophenoxazine 
moiety loaded in these materials. On the contrary, the other absorption bands at λ∼400, 590 and 
700 nm were not only encountered in the spectra of M1 and M2, but also observed for guest-free 
M0. These can be ascribed to intraligand and metal-to-ligand/ligand-to-metal charge transfer 
electronic transitions of the [Co(bix)(3,5-dbsq)(3,5-dbcat)] system. 26  Noticeably, these 
absorption bands corresponding to the coordination complex units expand all over the UV, vis 
and NIR regions, and therefore they overlap with the emission spectrum of the 
benzophenoxazine dye (see Fig. 2a). Consequently, efficient quenching of dye fluorescence via 
resonant energy transfer processes is expected in the interior of the nanoparticles, where these 
moieties will be located at the near proximity of coordination complex units regardless of 
whether they are directly coordinated to the metal centre or physically encapsulated within the 
polymer network. Indeed, no red fluorescence could be measured for M1 and M2 particles in the 
solid state, which confirms effective quenching of the emission of the loaded guests (Fig. 4b). 
Fluorescence quenching is however inhibited upon guest release and CPP degradation, which 
allowed us to monitor the delivery of the particle cargo by means of highly sensitive emission 
measurements (vide infra). This was demonstrated by measuring the optical properties of M0, 
M1 and M2 in non-degassed methanol, where particle dissolution is followed by coordination 
polymer degradation via ligand exchange and concomitant oxidation of the catecholate and 
semiquinone groups. This leads to disappearance of the absorption bands associated to the 
[Co(bix)(3,5-dbsq)(3,5-dbcat)] coordination polymers as well as pronounced growth of the band 
at λ∼400 nm corresponding to the quinone species resulting from catecholate and semiquinone 
degradation (see Fig. S2 in the Supporting Information).27 Accordingly, no energy transfer 
processes are expected under such conditions and an enormous increase in benzophenoxazine 
emission was indeed measured (Fig. 4b). The absorption measurements in non-degassed 
methanol were also used to quantify the encapsulation efficiencies for the preparation of dye-
doped M1 and M2 particles. Interestingly, higher values were obtained for M1 (∼20%) than for 
M2 (∼10%) under equivalent experimental conditions, which indicates that incorporation of the 
fluorescent guest bearing a coordinating catechol moiety is significantly more effective. 
Valence tautomerism of M1 and M2 CPPs. The amorphous nature of M1 and M2 
nanoparticles precludes any accurate structural characterisation by classical diffraction 
techniques. Nevertheless, we exploited the valence tautomerism (VT) behaviour shown by 
[Co(bix)(3,5-dbsq)(3,5-dbcat)] CPPs18,19 to investigate the structural similarities between M1 
and M2. These systems might interconvert reversibly between the low-spin ls-[CoIII(bix)(3,5-
dbsq)(3,5-dbcat)] and high-spin hs-[CoII(bix)(3,5-dbsq)2] tautomers by intramolecular metal-
ligand electron transfer, a process that can be selectively monitored by temperature dependent 
measurements of magnetic susceptibility.  
Fig. 5 plots the results obtained in those measurements for M0, M1 and M2. In all cases, an 
abrupt change in effective magnetic moment (µeff) is observed around 300 K, which is consistent 
with valence-tautomeric interconversion from low- to high-spin states for a large fraction of 
molecules in the nanoparticles.18 Importantly, the occurrence of valence tautomerism and the 
actual profile of the corresponding µeff vs T plot is not only highly sensitive to metal complex 
composition and structure, but also to the local environment.19 In other words, the same complex 
may exhibit or not VT, or the low-spin-to-high-spin conversion might take place at different 
temperatures depending on structural and environmental parameters. Therefore, the extremely 
similar magnetic behaviour encountered for M0, M1 and M2 clearly indicates that they must be 
formed by equivalent coordination polymers in rather comparable phases. 
Guest release mechanisms. To investigate guest release from M1 and M2, colloidal 
suspensions were prepared in phosphate buffered saline solutions (PBS) at pH=7.4, placed in a 
dialysis bag (cut-off molecular weight: 3500 Da) at 37ºC, and finally dialysed against PBS for 
100 hours. Relative cumulative release profiles were then measured by monitoring the 
fluorescence of the dialysis bath solution in time. In addition, the solid material remaining in the 
dialysis bag after 100 hours was dissolved in methanol and characterised by absorption 
spectroscopy, which allowed us to determine the absolute release efficiency of the dialysis 
experiment. Fig. 6 plots the cumulative release profiles measured for M1 and M2 under these 
experimental conditions. Both exhibit very high release efficiencies after 100 hours (~90%) with 
no “burst effects” associated to undesired desorption of guest molecules physisorbed onto the 
nanoparticle surface. However, the release kinetics measured for these materials were found to 
be strikingly different. In the case of M2, the delivery process was nearly completed after 8 h 
(t1/2 ~1.2 h), a behaviour resembling that already reported for the release of anticancer drugs 
mechanically entrapped in analogue [Zn(bix)] CPPs.16 In contrast, a much slower process was 
observed for M1, which required about 100 h for completion (t1/2 ~11 h). 
On the basis of the non-coordinating nature of the encapsulated guest, the release profile of 
M2 at 37ºC was fitted with a purely diffusion-controlled model of drug delivery. In particular, 
we considered the use of equation (1), which was derived for drug delivery via Fickian diffusion 
from spherical particles with homogenous and low-doping loads that do not significantly swell or 
degrade during the release process:28 
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In this equation, Mt and M∞ represent the cumulative absolute amounts of guest released at time t 
and infinity, R is the radius of the particles and D is the apparent diffusion constant of the drug 
within the system. D is the only variable parameter in this model, which is taken to remain 
constant throughout the release process by neglecting swelling and degradation effects on the 
structure of the polymeric drug carrier. 
As observed in Fig. 6, a rather satisfactory fit of the experimental release kinetics of M2 was 
obtained using equation (1). Therefore, the delivery of the mechanically-entrapped fluorescent 
guest must be governed by a time-independent diffusion mechanism (D = 6.9x10-19 m2 s-1), 
which indicates that the influence of degradation processes on the release kinetics is negligible in 
this case even though it takes place. This is proven by Fig. 7, which displays SEM images of M2 
nanoparticles suspended in aqueous media at 37ºC for 0, 5, 26 and 100 h. While most particles 
preserved their spherical shape after 5 h, extensive surface erosion and an increasing amount of 
non-structured material is observed in the SEM images registered at 26 and 100 h. This confirms 
CPP degradation, which however takes place at a longer time scale than guest diffusion from the 
nanoparticles at 37ºC. This is in contrast with other systems for which clearly different delivery 
phases are observed that are ascribed to the occurrence of sequential fast diffusion and slow 
degradation processes.7-9 
The release profile obtained for M1 at 37ºC was also tentatively fitted with single-mechanism 
models, which in this case should solely account for degradation-controlled delivery. However, 
poor agreement between the experimental and fitted release profiles was obtained regardless of 
using surface-degradation29 or bulk-degradation30 models of drug delivery. This suggests the 
occurrence of a more complex release process, which we attempted to model by assuming 
simultaneous delivery via degradation and diffusion processes. In this scenario, degradation-
controlled release should apply for all guest molecules coordinated to the polymeric backbone, 
while those that remain unbound but physically entrapped within the metal-organic matrix 
should be preferentially delivered by fast diffusion processes. Based on the previous results 
obtained for M2 and analogue [Zn(bix)] CPPs,16 equation (2) was derived to account for such 
situation: 
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The first term in this equation corresponds to the Fickian diffusion model already applied to M2, 
where b is the fraction of guest molecules that lie mechanically entrapped within M1 particles. 
As previously discussed, this model assumes that the diffusion-controlled release of guest 
molecules takes place before significant degradation of the polymer matrix occurs, which allows 
the particle radius and the apparent guest diffusion constant to be considered time independent. 
This assumption is not only supported by the behaviour observed for M2, but also by the similar 
results obtained when monitoring the degradation process of M1 nanoparticles at 37ºC in water 
media using SEM (see Fig. S3 in the Supporting Information). The second term in equation (2) 
corresponds to an empirical model that has been developed for degradation-controlled drug 
delivery from spherical particles via surface erosion,29 which is indeed the degradation 
mechanism reported for analogue [Zn(bix)] CPPs at physiological conditions.16 In this 
expression (1-b) is the fraction of guest molecules coordinated to the metal centres in M1, kd is 
the surface erosion rate constant, C0 is the total initial concentration of the guest in the polymer 
matrix (7.2x10-4 % (w/w)) and R is the initial radius of the nanoparticles. 
To fit equation (2) to the guest release profile measured for M1 at 37ºC, only two variable 
parameters were considered: b and kd. To test the consistency of our model, D was directly taken 
from the previous fit of M2 delivery kinetics, a rather plausible constraint based on the very 
similar structures of the guest compounds and coordination polymer particles investigated in this 
work. As observed in Fig. 6, a good agreement was encountered between the experimental and 
fitted release profiles of M1 even under such assumption, which proves the validity of our 
treatment (b = 0.26, kd /(C0 R)= 1.7x10-6 s-1). From this we conclude that most guest molecules in 
M1 nanoparticles (74%) are directly bound to the polymer matrix, which are therefore released 
by slow degradation of the material. Nevertheless, a significant fraction of them (26%) are not 
coordinated to cobalt ions despite presenting free catechol groups, but they were physically 
encapsulated during the formation of the particles. Accordingly, they are delivered via a fast 
time-independent diffusion mechanism similar to that encountered for M2 CPPs. 
Additional guest release experiments were performed at 60ºC aiming at investigating the 
temperature dependence of the delivery processes in these materials (see Fig. S4 in the 
Supporting Information). In deep contrast to what had been observed at 37ºC, no significant 
differences were found between the release profiles measured for M1 and M2 at this temperature. 
In both cases, complete delivery of the fluorescence guests is observed at ∼5 h, revealing the 
occurrence of much faster release processes. This suggests that degradation kinetics enormously 
accelerates at 60ºC, which must become at least comparable to guest diffusion rates. As a matter 
of fact, we expect the release profiles of M1 and M2 CPPs at these conditions to be mainly 
governed by degradation processes, which indicates that both the guest delivery kinetics and 
mechanisms of these materials can be dramatically altered by temperature control. 
 
Conclusion 
In this work we report a novel rational approach to investigate the relationship between guest 
encapsulation and release mechanisms for metal-organic nanoparticles. By proper design of the 
guest compounds and particle formation conditions, two types of coordination polymer particles 
were prepared that (1) are compositionally and structurally equivalent, and (2) were loaded with 
the same fluorescent guests using different encapsulation processes. As a result, the release of 
their fluorescent cargo at physiological conditions proceeds via distinct mechanisms that 
converge upon increasing the temperature. Physically encapsulated guest molecules are delivered 
by fast time-independent diffusion processes, while the release of coordinated guest moieties is 
governed by slow particle degradation. This leads to remarkably different guest delivery profiles 
for the CPPs prepared, which demonstrates that the kinetics of release can be selectively tuned 
up to many hours by appropriate choice of the mechanism of incorporation of the therapeutic 
agent into the polymeric nanocarrier. This result opens new venues for the future use of CPPs in 
medicine owing to the feasibility of loading drugs into these carriers by both mechanical 
entrapment and chemical binding to the metal centres. The former encapsulation mechanism has 
indeed already been demonstrated for anticancer drugs,16 while tethering of these molecules to 
coordinating ligands could be attempted via functional groups that are readily cleaved at 
physiological conditions (e.g. ketals31), thus rendering the active form of the therapeutic agent 
after degradation-induced release from the polymer particles. As a result, controlling the ratio of 
coordinated vs. physically entrapped drug molecules within CPPs would eventually allow 
tailoring the release kinetics to meet the therapeutic needs. 
 
Experimental Section 
Materials and characterisation: All reactants and reagents were purchased from Sigma-Aldrich 
and used as received. Solvents were purchased from Scharlab and used as received. Dialysis bags 
were purchased from Orange Scientific.Infrared spectra were recorded on a Bruker Tensor 27 
spectrometer equipped with a Golden Gate Single Reflection Diamond ATR (Attenuated Total 
Reflectance) accessory. High resolution mass analyses were performed on an ESI-QTOF Bruker 
Daltonics micrOTOF-Q spectrometer. NMR spectra were recorded on a Bruker ARX 400 (400 
MHz for 1H NMR and 100 MHz for 13C NMR). The spectra are given in δ (ppm) using the signal 
of the residual non-deuterated solvent molecules as reference. Absorption spectra were recorded 
on a Hewlett Packard 8453 spectrophotometer. HPLC or spectroscopy quality solvents were used. 
Emission spectra were measured by means of a custom-made spectrofluorimeter, where a cw He-
Ne REO laser (λexc = 594 nm) was used as excitation source and the emitted photons were 
detected in an Andor ICCD camera coupled to a spectrograph. HPLC or spectroscopy quality 
solvents were used. Fluorescence quantum yields were determined using Nile Blue A in ethanol 
solution as reference (Φf =0.27).32 SEM measurements were registered on a HITACHI S-570 
microscope (accelerating voltage 0.5–30 kV). TEM measurements were carried out on a 
HITACHI-7000 microscope operating at 125 kV. 
Synthesis of compound 4a: This compound was prepared according to ref. [21] with some 
modifications. Demethylation: To a solution of 3 (0.845 g, 4 mmol) in CH2Cl2 (30 mL) cooled 
down in a liquid nitrogen bath, 4 mL of 1 M solution of BBr3 in CH2Cl2 were added dropwise. 
Next, the reaction was allowed to proceed at room temperature for 2 h. The reaction mixture was 
poured in 40 ml distilled water and the resulting aqueous layer was extracted twice with CH2Cl2 
(30 mL). The organic extracts were dried with MgSO4 and the solvent evaporated under vacuum 
to afford the demethylated compound as a yellowish solid (0.698 g, 90 %). This compound was 
used in the next step without further purification. Protection of the catechol: To a solution of this 
intermediate (0.492 g, 2.54 mmol) in CH2Cl2 (8 mL) cooled down in a water bath, the following 
compounds were added dropwise: DIPEA (2.7 mL, 15.5 mmol), DMAP (30 mg, 0.22 mmol) and 
methoxymethyl bromide (0.65 mL, 8.02 mmol). The solution was heated under reflux for 8 h. 
The reaction mixture was treated with water (15 mL) and the resulting aqueous layer was 
extracted twice with CH2Cl2 (15 mL). The organic extracts were dried with MgSO4 and the 
solvent evaporated under vacuum. Crude was purified by flash chromatography using hexanes 
and ethyl acetate (4:1, v/v) to afford 4a (0.716 g, 100 %) as a yellowish oil. 1H RMN (400 MHz, 
CDCl3, 25ºC, TMS): δ = 9.87 (s, 1H), 7.55 (s, 2H), 5.31 (s, 2H), 5.23 (s, 2H), 3.66 (s, 3H), 3.52 
(s, 3H), 1.45 ppm (s, 9H); 13C RMN (100 MHz, CDCl3, 25ºC, TMS): δ = 191.5, 151.9, 150.4, 
144.0, 131.5, 123.8, 114.5, 99.4, 95.4, 57.9, 56.6, 35.4, 30.3 ppm; IR (ATR): ν = 3076.2, 2953.3, 
2905.4, 2826.8, 1690.1, 1578.5 cm-1; HRMS (ESI-QTOF): m/z calcd for C15H22NaO5: 305.1359; 
found: 305.1356.  
Synthesis of 4b: This compound was prepared according to ref. [22] with some modifications. 
To a solution of 3 (3.5 g, 16.8 mmol) in DMF (100 mL), K2CO3 (6.95 g, 50.4 mmol) and N,N,N-
tributyl-1-butanaminium iodide (270 mg, 0.73 mmol) were added. The reaction mixture was 
stirred for 2 h at room temperature. After this time, Me2SO4 (3.2 mL, 33.6 mmol) was added 
dropwise and the mixture was allowed to react for 16 h. The resulting mixture was treated with 
water (100 mL) and the aqueous layer was extracted four times with EtOAc (50 mL). The 
organic extracts were dried with MgSO4 and the solvent evaporated under vacuum to afford 4b 
(3.36 g, 90 %) as a dark green oil. 1H RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 9.91 (s, 1H), 
7.48 (d, J = 1.9 Hz, 1H), 7.38 (d, J = 1.9 Hz, 1H), 3.97 (s, 3H), 3.94 (s, 3H), 1.44 ppm (s, 9H). 
Synthesis of 5a. To a solution of 4a (1.559 g, 5.53 mmol) in toluene (45 mL), 
(triphenylphosphoranylidene)acetonitrile (2.070 g, 6.87 mmol) was added. The reaction mixture 
was heated under reflux for 12h, after which the solvent was evaporated under vacuum and the 
residue was purified by flash chromatography using hexanes and ethyl acetate (6:1, v/v) to afford 
a mixture of (E)- and (Z)-5a (1.621 g, 96 %) as a brown oil with a diastereomeric ratio of 2.3:1. 
1H RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 7.57 (d, J = 2.2 Hz, 1H), 7.47 (d, J = 2.2 Hz, 1H), 
7.32 (d, J = 16.6 Hz, 1H), 7.16 (d, J = 2.2 Hz, 1H), 7.06 (d, J = 2.2 Hz, 1H), 7.03 (d, J = 12.0 Hz, 
1H), 5.75 (d, J = 16.6 Hz, 1H), 5.34 (d, J = 12.0 Hz, 1H), 5.26 (s, 2H), 5.24 (s, 2H), 5.21 (s, 2H), 
5.19 (s, 2H), 3.66 (s, 3H), 3.65 (s, 3H), 3.53 (s, 3H), 3.51 (s, 3H), 1.43 (s, 9H), 1.41 ppm (s, 9H); 
13C RMN (100 MHz, CDCl3, 25ºC, TMS): δ = 150.7, 150.5, 150.0 148.9, 148.7, 148.6, 143.9, 
143.8, 128.6, 128.5, 122.5, 121.0, 118.6, 117.9, 115.0 , 112.5, 99.3, 99.3, 95.5, 95.4, 94.8, 93.4, 
57.9, 57.9, 56.5, 56.6, 35.5, 35.3, 30.4, 30.3 ppm; IR (ATR): ν = 3371.2, 2953.8, 2213.6, 1615.5, 
1428.9 cm-1; HRMS (ESI-QTOF): m/z calcd for C15H22NaO5: 328.1519; found: 328.1519. 
Synthesis of 5b. Synthesised from 4b using the same procedure as for 5a. Yield = 72 % with a 
diastereomeric (E):(Z) ratio of 4.8:1. 1H RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 7.53 (d, J = 
2.1 Hz, 1H), 7.34 (d, J = 16.5 Hz, 1H), 7.23 (d, J = 2.1 Hz, 1H), 7.05 (d, J = 12.1 Hz, 1H), 7.00 
(d, J = 2.0 Hz, 1H), 6.88 (d, J = 2.0 Hz, 1H), 5.75 (d, J = 16.5 Hz, 1H, 4.39 (d, J = 12.1 Hz, 1H), 
3.92 (s, 3H), 3.92 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 1.39 (s, 9H), 1.37 ppm (s, 9H); 13C NMR 
(100 MHz, CDCl3, 25ºC, TMS): δ = 153.7, 153.4, 151.7, 151.2, 151.0, 149.2, 144.1, 143.7, 128.5, 
128.4, 122.0, 119.9, 119.8, 118.6, 110.2, 108.6, 94.5, 92.9, 60.7, 60.7, 56.0, 56.0, 35.3, 35.3, 30.4, 
30.4 ppm; IR (ATR): ν = 2952.0, 2213.3, 1615.6, 1571.5, 1415.0, 1142.9, 1067.0, 1023.7 cm-1; 
HRMS (ESI-QTOF): m/z calcd for C15H19NaNO2: 268.1308, found: 268.1309. 
Synthesis of 6a. A mixture of (E)- and (Z)-5a (1.442 g, 4.8 mmol) and 10% Pd/C (5:1, 
substrate/catalyst) in ethyl acetate (16 mL) was stirred at room temperature under hydrogen 
atmosphere for 24 h. Next, Pd/C was filtered off and the solvent was removed in vacuo. The 
residue was purified by flash chromatography using hexanes and ethyl acetate (3:1, v/v) to afford 
6a (1.003 g, 68 %) as a brown oil. 1H RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 6.90 (d, J  = 2.1 
Hz, 1H), 6.84 (d, J  = 2.1 Hz, 1H), 5.18 (s, 2H), 5.16 (s, 2H), 3.64 (s, 3H), 3.51 (s, 3H), 2.88 (t, J  
= 7.4 Hz, 2H), 2.58 (t, J = 7.4 Hz, 2H), 1.41 ppm (s, 9H); 13C RMN (100 MHz, CDCl3, 25ºC, 
TMS): δ = 150.6, 145.0, 143.9, 133.0, 120.6, 119.2, 114.7, 99.1, 95.6, 57.6, 56.4 , 35.3, 31.7, 
30.6, 19.6 ppm; IR (ATR): ν = 2952.2, 2904.6, 2826.2, 2374.0, 1602.7, 1433.6, 1154.6, 936.8 
cm-1; HRMS (ESI-QTOF): m/z calcd for C17H25NaNO4: 330.1376; found: 330.1375. 
Synthesis of 6b. Synthesised from 5b using the same procedure as for 6a. Yield = 67 %. 1H 
RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 6.74 (d, J = 2.1 Hz, 1H), 6.69 (d, J = 2.1 Hz, 1H), 3.86 
(s, 6H), 2.90 (t, J = 7.4 Hz, 2H), 2.60 (t, J = 7.4 Hz, 2H), 1.37 ppm (s, 9H); 13C RMN (100 MHz, 
CDCl3, 25ºC, TMS): δ = 171.5, 153.7, 148.0, 144.0, 133.0, 119.7, 119.0, 111.0, 60.8, 56.0, 35.0, 
32.2, 30.9 ppm; IR (ATR): ν = 2951.4, 2866.4, 2831.8, 2245.0, 1688.2, 1580.1, 1421.9, 1346.7, 
1260.0, 1067.6, 1006.1 cm-1; HRMS (ESI-QTOF): m/z calcd for C15H21NaNO2: 270.1465; 
found: 270.1465.  
Synthesis of 7a. To a suspension of LiAlH4 (298 mg, 7.9 mmol) in anhydrous Et2O (2 mL) 
cooled down in a water bath, a solution of 6a (695 mg, 2.2 mmol) in anhydrous Et2O (2 mL) was 
added dropwise. Next, the reaction mixture was stirred at room temperature for 14h under inert 
atmosphere. The reaction mixture was cooled down to 0 ºC and quenched with NaOH 1M (15 
mL). The resulting aqueous layer was extracted with Et2O (15 mL) and CHCl3 (15 mL). The 
combined organic extracts were dried with MgSO4 and the solvent removed in vacuo to afford 
7a (627 mg, 89 %) as a yellowish oil. This product was used without further purification. 1H 
RMN (400 MHz, CDCl3 25ºC, TMS): δ = 6.85 (d, J  = 2.0 Hz, 1H), 6.80 (d, J  = 2.0 Hz, 1H), 
5.17 (s, 2H), 5.16 (s, 2H), 3.64 (s, 3H), 3.50 (s, 3H), 2.73 (t, J = 7.6 Hz, 2H), 2.58 (t, J = 7.6 Hz, 
2H), 1.74 (qt, J = 7.6 Hz, 2H), 1.40 ppm (s, 9H); 13C RMN (100 MHz, CDCl3, 25ºC, TMS): δ = 
150.2, 143.9, 143.3, 137.2, 120.6, 114.7, 99.1, 95.5, 57.6, 56.4, 42.1, 35.7, 35.2, 33.4, 30.7 ppm; 
IR (ATR): ν = 3362.8, 2949.4, 1578.6, 1431.9, 1076.7, 961.7 cm-1; HRMS (ESI-QTOF): m/z 
calcd for C17H29NNaO4: 334.1989; found: 334.1979. 
Synthesis of 7b. Synthesised from 6b using the same procedure as for 7a. Yield = 76 %. 1H 
RMN (400 MHz, [D4]MeOD, 25ºC, TMS): δ = 6.74 (d, J  = 2.0 Hz, 2H), 3.82 (s, 3H), 3.80 (s, 
3H), 2.70 (t, J = 7.5 Hz, 2H), 2.58 (t, J = 7.5 Hz, 2H), 1.79 (qt, J = 7.5 Hz, 2H), 1.34 ppm (s, 
9H); 13C RMN (100 MHz, [D4]MeOD, 25ºC, TMS): δ = 153.5, 146.9, 142.7, 136.8, 118.7, 111.3, 
59.8, 55.3, 40.8, 34.8, 33.9, 33.3, 30.2 ppm; IR (ATR): ν = 3452.3, 2936.2, 1578.1, 1421.9, 
1321.1, 1262.1, 1144.8, 1066.5, 1008.1 cm-1; HRMS (ESI-QTOF): m/z calcd for C15H25NNaO2: 
252.1958; found: 252.1963. 
Synthesis of 8a. To a solution of 3-(naphthalen-1-ylamino)propanoic acid (646 mg, 3 mmol), 
HOBt (589 mg, 4.3 mmol), EDCI (760 mg, 3.9 mmol) and DIPEA (1.6 mL, 9.1 mmol) in 20 mL 
of anhydrous CH2Cl2, a solution of 7a (956 mg, 3 mmol) in 10 mL of anhydrous CH2Cl2 was 
added. The reaction mixture was stirred at room temperature for 17h. Then, it was washed twice 
with a solution of saturated NaHCO3 (10 mL) and once with a solution of saturated NaCl (10 
mL). The organic layer was dried with MgSO4 and solvent was evaporated under vacuum. Crude 
was purified by flash chromatography using hexanes and ethyl acetate (1:1, v/v) to afford 8a 
(482 mg, 31 %) as a brown oil. 1H RMN (400 MHz, CDCl3, 25ºC, TMS): δ = 7.81 (d, J = 8.1 Hz, 
1H), 7.74 (d, J = 7.6 Hz, 1H), 7.38 – 7.23 (m, 4H), 6.79 (d, J = 1.9 Hz, 1H), 6.4 (d, J = 1.9 Hz, 
1H), 6.58 (d, J = 7.6 Hz, 1H), 6.04 (s, 1H), 5.16 (s, 2H), 5.11 (s, 2H), 3.63 (s, 3H), 3.54 (t, J = 
6.02 Hz, 2H), 3.46 (s, 3H), 3.24 (dd, J = 13.1 Hz, J = 6.7 Hz, 2H), 2.50 (m, 4H), 1.73 (qt, J = 7.6 
Hz, 2H), 1.39 ppm (s, 9H); 13C RMN (100 MHz, CDCl3, 25ºC, TMS): δ = 171.9, 150.1, 143.4, 
143.1, 136.23, 134.4, 128.6, 126.5, 125.9, 124.9, 123.9, 120.4, 117.8, 114.5, 104.5, 99.0, 95.4, 
57.6, 56.4, 40.4, 39.3, 35.3, 35.2, 33.3, 31.2, 30.7 ppm; IR (ATR): ν = 3304.4, 2949.4, 1638.2, 
1580.4, 1526.7, 1199.4, 1035.5, 961.9 cm-1; HRMS (ESI-QTOF): m/z calcd for C30H40N2NaO5: 
531.2829; found: 531.2834.  
Synthesis of 8b: Synthesised from 7b using the same procedure as for 8a. Yield = 35 %. 1H 
RMN (400 MHz, [D4]MeOD, 25ºC, TMS): δ = 7.93 (d, J = 8.1 Hz, 1H), 7.69 (d, J = 7.9 Hz, 1H), 
7.41 – 7.23 (m, 3H), 7.14 (d, J = 8.1 Hz, 1H), 6.69 (d, J = 2.9 Hz, 1H), 6.69 (s, J = 2.9 Hz, 1H), 
6.65 (s, 1 H), 6.60 (d, J = 4.3 Hz, 2H), 3.76 (s, 3H), 3.69 (s, 3H), 3.54 (t, J = 6.60 Hz, 2H), 3.17 
(t, J = 7.00 Hz, 3H), 2.59 (t, J = 6.60 Hz, 2H), 2.53 – 2.45 (m, 4H), 1.73 (qt, J = 7.6 Hz, 2H), 
1.31 ppm (s, 9H); 13C RMN (101 MHz, [D4]MeOD, 25ºC, TMS): δ = 174.6, 154.3, 147.7, 144.7, 
143.5, 137.6, 135.8, 129.3, 127.6, 126.6, 125.4, 125.1, 121.7, 119.5, 118.1, 112.1, 105.1, 60.7, 
56.1, 41.6, 40.0, 36.3, 35.8, 34.2, 32.3, 31.1 ppm; IR (ATR): ν = 2919.5, 2478.6, 2065.58, 
1627.1, 1577.7, 1450.4, 1420.8, 1143.8, 1067.9 cm-1; HRMS (ESI-QTOF): m/z calcd for 
C28H36N2NaO3: 449.2799; found: 449.2804.  
Synthesis of 1. To a solution of N-ethyl-5-hydroxy-2-methyl-4-nitrosobenzenaminium chloride 
(72 mg, 0.4 mmol) in 1 mL of MeOH cooled down in a water bath and under inert atmosphere, a 
solution of 8a (170 mg, 0.33 mmol) in 1 mL of degassed MeOH and a 3 droplets of HCl 35 % 
were added. This mixture was heated under reflux for 1.5 h. Then it was cold down to room 
temperature and CH2Cl2 (5 mL) and a mixture of saturated NaCl (2 mL) and 3 droplets of HCl 
35 % were added. The resulting organic layer was washed twice with saturated NaHCO3 (3 mL) 
and once with saturated NaCl (3 mL). Next, it was dried with MgSO4 and solvent was removed 
in vacuo. Crude was purified by flash chromatography using CH2Cl2 and MeOH (10:1, v/v) to 
afford 1 (87 mg, 45 %) as a bluish-violet solid. 1H RMN (400 MHz, [D4]MeOD, 25ºC, TMS): δ 
= 8.73 (d, J = 8.1 Hz, 1H), 8.22 (d, J = 8.1 Hz, 1H), 7.82 (t, J = 7.5 Hz, 1H), 7.71 (t, J = 7.5 Hz, 
1H), 7.51 (s, 1H), 6.90 (s, 1H), 6.70 (s, 1H), 6.40 (s, 1H), 6.38 (s, 1H), 3.95 (t, J = 6.2 Hz, 2H), 
3.49 (q, J = 7.2 Hz, 3H), 3.21 (m , 2H), 2.75 (t, J = 6.2 Hz, 2H), 2.35 (m, 2H), 2.29 (s, 3H), 1.67 
(qt, J = 7.2 Hz, 2H), 1.46 ppm (s, 9H); 13C RMN (100 MHz, [D4]MeOD, 25ºC, TMS): δ = 172.9 
158.2, 156.9, 152.5, 149.3, 145.7, 143.3, 136.8, 133.9, 132.9, 132.6, 132.5, 132.4, 132.3, 130.7, 
129.0, 125.5, 124.5, 123.6, 118.2, 113.5, 94.5, 94.1, 41.9, 40.3, 39.8, 35.8, 34.0, 32.5, 30.1, 17.8, 
14.2 ppm; IR (ATR): ν = 3213.7, 3076.2, 2921.8, 2852.5, 1640.1, 1587.6, 1540.9, 1433.8, 
1307.7, 1160.8 cm-1; HRMS (ESI-QTOF): m/z calcd for C35H41N4O4+: 581.3122; found: 
581.3124. 
Synthesis of 2. Synthesised from 8b using the same procedure as for 1. Yield = 35 %. 1H RMN 
(250 MHz, [D4]MeOD, 25ºC, TMS): δ = 8.70 (d, J = 8.1 Hz, 1H), 8.20 (d, J = 8.1 Hz, 1H), 7.81 
(t, J = 7.6 Hz, 1H), 7.70 (t, J = 7.6 Hz, 1H), 7.48 (s, 1H), 6.91 (s, 1H), 6.70 (s, 1H), 6.51 (s, 1H), 
6.49 (s, 1H), 4.56 (s, 2H), 3.97 (t, J = 5.9 Hz, 2H), 3.74 (s , 3H), 3.70 (s , 3H), 3.49 (q, J = 6.2 
Hz, 2H), 3.22 (t, 2H, J = 6.8 Hz, 2H), 2.77 (t, J = 5.9 Hz, 2H), 2.39 (t, J= 6.8 Hz, 2H), 2.28 (s, 
3H), 1.68 (qt, J = 6.8 Hz, 2H), 1.43 – 1.23 ppm (m, 12H); 13C RMN (63 MHz, [D4]MeOD, 25ºC, 
TMS): δ = 173.0, 158.2, 156.8, 154.3, 152.5, 149.2, 147.8, 143.6, 140.2, 137.4, 133.9, 132.9, 
132.6, 132.2, 130.7, 129.0, 125.5, 124.5, 123.6, 119.4, 114.7, 112.1, 94.5, 60.7, 56.2, 41.9, 40.2, 
39.8, 35.7, 34.9, 34.2, 33.0, 32.4, 31.9, 31.1 ppm; IR (ATR): ν = 2920.8, 2851.6, 1640.4, 
1588.12, 1541.4, 1451.0, 1310.0, 1160.9, 1133.6, 1006.6 cm-1; HRMS (ESI-QTOF): m/z calcd 
for C37H44N4NaO4: 609.3435; found: 609.3435.  
Synthesis of M0. To a solution of di-tert-buthylcathecol (107.2 mg, 0.48 mmol) and 1,4-
bis(imidazol-1-ylmethyl)benzene (59.6 mg, 0.25 mmol) in EtOH (5 mL), 1 mL of an aqueous 
solution of Co(CH3COO)2·4H2O (61.7 mg, 0.24 mmol) was added dropwise. The mixture was 
stirred for 10 min and then the formation of nanoparticles was induced by fast addition of 25 mL 
of miliQ H2O. Ligand excess was removed by centrifugation and the nanoparticles were washed 
three times with H2O. 
Synthesis of M1. To a solution of 1 (5.5 mg, 9.5 µmol), di-tert-buthylcathecol (211.5 mg, 0.95 
mmol) and 1,4-bis(imidazol-1-ylmethyl)benzene (117.3 mg, 0.49 mmol) in EtOH (20 mL), 4 mL 
of an aqueous solution of Co(CH3COO)2·4H2O (121.4 mg, 0.49 mmol) were added dropwise. 
The mixture was stirred for 10 min and then the formation of nanoparticles was induced by fast 
addition of 100 mL of miliQ H2O. Ligand excess was removed by centrifugation and the 
nanoparticles were washed with a mixture of EtOH:H2O (v/v 1:5) until no red fluorescence was 
observed from the supernatant solution. 
Synthesis of M2. To a solution of 2 (3.1 mg, 5.1 µmol), di-tert-buthylcathecol (120 mg, 0.53 
mmol) and 1,4-bis(imidazol-1-ylmethyl)benzene (65 mg, 0.27 mmol) in EtOH (10 mL), 2 mL of 
an aqueous solution of Co(CH3COO)2·4H2O (68.9 mg, 0.28 mmol) were added dropwise. The 
mixture was stirred for 10 min and then the formation of the nanoparticles was induced by fast 
addition of 50 mL of miliQ H2O. Ligand excess was removed by centrifugation and the 
nanoparticles were washed with a mixture of EtOH:H2O (v/v 1:5) until no red fluorescence was 
observed from the supernatant solution. 
Guest release experiments. A dialysis bag (cut-off molecular weight: 3500) containing M1 or 
M2 (c ~ 3 mg/mL) dispersed in phosphate buffered saline solution (PBS; pH = 7.4) was placed 
in 150 mL of PBS (pH = 7.4; dialysate) at 37 ºC under light stirring. To determine the increase of 
1 or 2 concentration diffused through the dialysis bag, 0.5 mL of external PBS solution were 
taken from the dialysate at prefixed times and diluted in 2 mL of MeOH, and each aliquot was 
analyzed by fluorescence spectroscopy. The solid material remaining in the dialysis bag after 100 
hours was dissolved in methanol and characterised by absorption spectroscopy. 
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Scheme and figure captions 
 
Scheme 1. Synthesis of fluorescent guests 1 and 2. (a) t-BuOH, H3PO4, 80 ºC, 10 h; (b) Br2, t-
BuOH, rt, 4 h; (c) BBr3, CH2Cl2, rt, 3 h; (d) MOMCl, DIPEA, DMAP, CH2Cl2, reflux, 24 h; (e) 
Me2SO4, K2CO3, (n-Bu)4NI, DMF, rt, 15 h; (f) Ph3PCHCN, toluene, reflux, 18 h; (g) H2 (2 atm), 
Pd/C, EtOAc 18 h; (h) LiAlH4, anh THF, addition at 0 ºC, then rt, 15 h; (i) 3-(naphthalen-1-
ylamino)propanoic acid, EDCI, DIPEA, CH2Cl2, rt, 18 h; (j) N-ethyl-5-hydroxy-2-methyl-4-
nitrosobenzenaminium chloride, HCl, MeOH, reflux, 2 h. 
 Figure 1. Chemical structures of fluorescent guest compounds 1 and 2, with which M1 and M2 
coordination polymer particles were prepared to investigate degradation- and diffusion-
controlled release from CPPs. 
 
 
Figure 2. Absorption and fluorescence emission spectra of fluorescent guests 1 (solid) and 2 
(dashed). 
 
 
 Figure 3. (a) Schematic synthesis of CPPs doped with fluorescent guests 1 and 2. (b-c) SEM 
(left) and TEM (right) images of M1 (b) and M2 (c) particles. Scale bars for SEM are 1 µm and 
for TEM are 200 nm. 
 
Figure 4. µeff values as function of temperature for M0 (triangles), M1 (squares) and M2 
(circles) CPPs. 
 Figure 5. (a) Absorption spectra of M0 (dotted), M1 (solid) and M2 (dashed) in degassed 
MeOH. (b) Fluorescence emission spectra recorded in degassed MeOH of M1 (solid) and M2 
(dashed) and in non-degassed MeOH of M1 (dotted dash) and M2 (dotted). 
 
Figure 6. Guest release profiles of fluorescent guest molecules from M1 (squares) and M2 
(circles) at 37 ºC, which were averaged over 4 independent experiments. Lines correspond to fits 
of the experimental data as described in the text. 
 Figure 7. SEM images of M2 CPPs suspended at 37 ºC in aqueous media for (a) 0 h, (b) 5 h, (c) 
26 h and (d) 100 h. Scale bars are 500 nm. 
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